2 ASX All Ordinaries stocks leaping higher following strong quarters

Let's dive into why these All Ords shares are besting the index on Thursday.

| More on:
Man pointing at a blue rising share price graph.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The All Ordinaries Index (ASX: XAO) is having a rough session on Thursday, but two stocks are defying the slump.

While the All Ords is falling 0.4% to 7,472.9 points, these stocks are leaping as much as 7% on the back of strong quarterly updates.

2 ASX All Ordinaries stocks surging on quarterly updates

Helloworld Travel Ltd (ASX: HLO)

First up, All Ordinaries travel stock Helloworld is soaring 7.43% today to trade at $2.89.

It comes on news the company's underlying earnings before interest, tax, depreciation, and amortisation (EBITDA) jumped to $14.2 million last quarter. That's up from a $4.9 million loss in the prior comparable period.

Its total transaction value (TTV) also shot 150% higher to $596.2 million while its revenue launched 240% to $46.9 million.

Also excitingly, Helloworld bolstered its full-year guidance on the back of its strong performance.

It now expects to post between $38 million and $42 million of underlying EBITDA for financial year 2023 – a $10 million improvement on its previous forecasts.

Incannex Healthcare Ltd (ASX: IHL)

Joining Helloworld stock in the green is that of Incannex. The pharmaceutical development company's share price is roaring 4.35% higher to trade at 12 cents at the time of writing.

The company released its update on the March quarter this morning, within which it narrowed the timeframe for the commercialisation of its psychedelic-assisted psychotherapy business, Psychedelic Clinics.

The first 'model' clinic is on track to be ready to open in Melbourne before September. It will be capable of treating over 600 patients per year during normal working hours.

The company also continued activities associated with the dosing of trial participants in its bioavailability and bioequivalence (BA/BE) clinical trial, assessing the pharmacokinetics and tolerability of the two active pharmaceutical ingredients in IHL-42X.

It's aiming to submit an investigational new drug (IND) application with the US Food and Drug Administration (FDA) this quarter.

Incannex posted around $4.3 million of cash outflows last quarter to end the period with $37.1 million of cash.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Helloworld Travel. The Motley Fool Australia has positions in and has recommended Helloworld Travel. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »